17.68

2.07% 0.3053

Eton Pharmaceuticals Inc (ETON)

Overview News Price History Option Chain Financials Discussions Forecast

Eton Pharmaceuticals Inc stock is traded at $17.68, with a volume of 119.48K. It is up +2.07% in the last 24 hours and up +47.87% over the past month. Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Previous Close:

$17.37

Open:

$17.96

24h Volume:

119.48K

Relative Volume:

0.44

Market Cap:

$452.51M

Revenue:

$31.38M

Net Income/Loss:

$-6.69M

P/E Ratio:

-67.98

EPS:

-0.26

Net Cash Flow:

$-1.84M

1W Performance:

+0.28%

1M Performance:

+47.87%

6M Performance:

+408.02%

1Y Performance:

+287.12%

1-Day Range:

$17.46

$18.33

1-Week Range:

$16.57

$18.41

52-Week Range:

$3.03

$18.41

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

Name

Eton Pharmaceuticals Inc

Sector

Healthcare (1187)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

(847) 787-7361

Address

21925 W. FIELD PARKWAY, DEER PARK, IL

Employee

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

ETON's Discussions on Twitter

Compare ETON with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ETON Eton Pharmaceuticals Inc	17.61	452.51M	31.38M	-6.69M	-1.84M	-0.26
ZTS Zoetis Inc	171.42	78.56B	9.15B	2.43B	2.31B	5.32
TAK Takeda Pharmaceutical Co Adr	13.54	43.15B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	9.545	43.00B	14.26B	1.55B	0	0.3383
TEVA Teva Pharmaceutical Industries Ltd Adr	16.62	19.59B	16.54B	-1.64B	749.00M	-1.45
NBIX Neurocrine Biosciences Inc	124.14	15.24B	2.24B	385.90M	440.10M	3.73

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-23-25	Reiterated	H.C. Wainwright	Buy
Jan-10-25	Initiated	B. Riley Securities	Buy
Jan-06-25	Reiterated	H.C. Wainwright	Buy
Sep-04-24	Resumed	H.C. Wainwright	Buy
May-06-24	Initiated	Craig Hallum	Buy
Oct-14-21	Resumed	B. Riley Securities	Buy
Jan-04-21	Reiterated	H.C. Wainwright	Buy
Sep-20-19	Initiated	B. Riley FBR	Buy
Jun-10-19	Initiated	H.C. Wainwright	Buy

View All

Eton Pharmaceuticals Inc Stock (ETON) Latest News

07:58 AM

Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) 45% Jump Shows Its Popularity With Investors - Simply Wall St

07:58 AM

07:12 AM

Eton Pharmaceuticals Says US Patent Granted for ET-600 Formulation -February 07, 2025 at 07:09 am EST - Marketscreener.com

07:12 AM

07:10 AM

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600 - The Manila Times

07:10 AM

06:50 AM

Major Patent Win: Eton's Game-Changing Liquid Diabetes Drug Gets 20-Year Protection - StockTitan

06:50 AM

Feb 06, 2025

FDA extends target action date for Eton's ET-400 - MSN

Feb 06, 2025

Eton Pharmaceuticals Says ET-400 FDA Decision Delayed to May -February 06, 2025 at 10:15 am EST - Marketscreener.com

Feb 06, 2025

Eton Pharmaceuticals : FDA Extends ET-400 Review to Late May -February 06, 2025 at 08:37 am EST - Marketscreener.com

Feb 06, 2025

Eton Pharmaceuticals: FDA Extends ET-400 Review to Late May - MarketWatch

Feb 06, 2025

Eton Pharmaceuticals: FDA extends PDUFA date for NDA for ET-400 to 5/28 - TipRanks

Feb 06, 2025

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400 - GlobeNewswire

Feb 06, 2025

Eton's Pediatric Rare Disease Drug Faces 3-Month FDA Review ExtensionRevenue Outlook Unchanged - StockTitan

Feb 06, 2025

Feb 03, 2025

Baader Bank Aktiengesellschaft Takes $373,000 Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - MarketBeat

Feb 03, 2025

Jan 29, 2025

Eton Pharmaceuticals Stock Hits All-Time High of $17.57 - MSN

Jan 29, 2025

Jan 28, 2025

Eton Pharmaceuticals Stock Hits All-Time High of $17.57 By Investing.com - Investing.com Nigeria

Jan 28, 2025

Jan 27, 2025

Here's What Could Help Eton Pharmaceuticals (ETON) Maintain Its Recent Price Strength - Yahoo Finance

Jan 27, 2025

Q2 EPS Estimate for Eton Pharmaceuticals Lifted by Analyst - MarketBeat

Jan 27, 2025

Q2 EPS Estimate for Eton Pharmaceuticals Raised by Analyst - Defense World

Jan 27, 2025

Jan 25, 2025

Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum - Yahoo Finance

Jan 25, 2025

Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength? - MSN

Jan 25, 2025

HC Wainwright Has Negative Outlook for ETON Q1 Earnings - Defense World

Jan 25, 2025

Jan 24, 2025

Q1 EPS Forecast for Eton Pharmaceuticals Lowered by Analyst - MarketBeat

Jan 24, 2025

Jan 23, 2025

Westside Investment Management Inc. Sells 43,453 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - MarketBeat

Jan 23, 2025

HC Wainwright Issues Positive Forecast for Eton Pharmaceuticals (NASDAQ:ETON) Stock Price - MarketBeat

Jan 23, 2025

Jan 22, 2025

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even - Simply Wall St

Jan 22, 2025

Eton Pharmaceuticals stock soars to all-time high of $15.11 - MSN

Jan 22, 2025

Eton Pharmaceuticals stock soars to all-time high of $15.11 By Investing.com - Investing.com Australia

Jan 22, 2025

Jan 20, 2025

Eton acquires Wilson disease drug Galzin - MSN

Jan 20, 2025

Jan 15, 2025

14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey

Jan 15, 2025